TY  - BOOK
AU  - Ratwani, Ankush P
TI  - Connective tissue disease-associated interstitial lung disease and outcomes after hospitalization: A cohort study
SN  - 0954-6111
PY  - 2019///
KW  - *Connective Tissue Diseases/co [Complications]
KW  - *Hospitalization/sn [Statistics & Numerical Data]
KW  - *Lung Diseases, Interstitial/co [Complications]
KW  - Adult
KW  - Aged
KW  - Case-Control Studies
KW  - Cohort Studies
KW  - Connective Tissue Diseases/ep [Epidemiology]
KW  - Connective Tissue Diseases/mo [Mortality]
KW  - Female
KW  - Hospitalization/td [Trends]
KW  - Humans
KW  - Lung Diseases, Interstitial/ep [Epidemiology]
KW  - Lung Diseases, Interstitial/mo [Mortality]
KW  - Lung Transplantation/mo [Mortality]
KW  - Male
KW  - Middle Aged
KW  - Non-Randomized Controlled Trials as Topic
KW  - Outcome Assessment, Health Care
KW  - Retrospective Studies
KW  - Risk Assessment
KW  - Survival Analysis
KW  - Tertiary Care Centers
KW  - MedStar Washington Hospital Center
KW  - Medicine/Internal Medicine
KW  - Journal Article
N2  - BACKGROUND: The impact of hospitalization on patient outcomes is increasingly recognized and considered in the prognostication of many pulmonary disorders. We sought to evaluate the impact of hospitalization on survival in connective tissue disease-interstitial lung disease (CTD-ILD) patients; CONCLUSION: This study highlights the impact of hospitalization on subsequent outcomes in the CTD-ILD population with a significantly reduced transplant-free survival demonstrated, especially after cardiopulmonary hospitalization events; Copyright Published by Elsevier Ltd; METHODS: A chart review of patients with CTD-ILD followed at a tertiary care center was performed. Patients were stratified into two groups based on hospitalization status. Outcomes of the groups were compared using Kaplan-Meier survival analyses as well as multivariate competing risk analysis; RESULTS: There were 137 patients identified with confirmed CTD-ILD. Patients who underwent hospitalization for any reason had a significant decrease in transplant-free survival compared to the never hospitalized cohort (3-year survival 60% vs. 94%; p=0.0001). Hospitalization for >=7 days was associated with worse outcomes than those hospitalized for <7 days (median survival 1.59 years vs. 7.17 years, p=0.0012). Based on multivariate competing risk analysis, factors associated with death, with lung transplantation as a competing risk, were age (HR=1.05 [95% 1.01-1.09]; P=0.0443), male gender (HR=4.94 [95% CI: 1.58-15.41]; P=0.006), and all cause hospitalization (HR=11.97 [95% CI: 1.36-105.49]; P=0.0253)
UR  - https://dx.doi.org/10.1016/j.rmed.2019.05.020
ER  -